Skip to main content

7 Result(s)

within I Simonitsch-Klupp Remove this filter

and

  1. Article

    Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

    Correction to: Leukemia (2016) 30, 1126–1132; doi:10.1038/leu.2015.360 Following the publication of this Article, the authors noted that there were errors in Tables 2 and 4. The correct tables are provided bel...

    H Gisslinger, G Jeryczynski, B Gisslinger, A Wölfler, S Burgstaller… in Leukemia (2017)

    Download PDF (97 KB) View Article

  2. Article

    Open Access

    Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

    Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of Standards in Haematology (BCSH) criteria that are predominantly based on exclusion and not necessarily on bone marrow (B...

    H Gisslinger, G Jeryczynski, B Gisslinger, A Wölfler, S Burgstaller… in Leukemia (2016)

    Download PDF (297 KB) View Article

  3. No Access

    Article

    Remission of pure red cell aplasia in T-cell receptor γδ-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab

    C Schützinger, A Gaiger, R Thalhammer, M Vesely, R Fritsche-Polanz… in Leukemia (2005)

  4. No Access

    Article

    Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites

    Although several recurrent genetic aberrations are known to occur in MALT lymphoma, no comprehensive study on the most prevalent MALT lymphoma-associated genetic aberrations is available. We therefore screened...

    B Streubel, I Simonitsch-Klupp, L Müllauer, A Lamprecht, D Huber, R Siebert… in Leukemia (2004)

  5. No Access

    Article

    Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)

    The prognostic value of the detection of peripheral blood (PB) and/or bone marrow (BM) involvement by polymerase chain reaction (PCR) amplification of rearranged immunoglobulin heavy chain (IgH) and immunoglob...

    G Mitterbauer-Hohendanner, C Mannhalter, K Winkler, M Mitterbauer, C Skrabs… in Leukemia (2004)

  6. No Access

    Article

    Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

    To define reproducible criteria for subgroups of diffuse large B-cell lymphomas (DLBCL), including lymphomas with plasmablastic/plasmacytoid features (PB/PC-Fs), we investigated 66 DLBCL; the samples were cate...

    I Simonitsch-Klupp, I Hauser, G Ott, J Drach, J Ackermann, J Kaufmann… in Leukemia (2004)

  7. No Access

    Article

    Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma

    Mutations or deletions in the SH2D1A (src homology 2 domain protein 1A) gene result in a severe immunodeficiency called X-linked lymphoproliferative (XLP) disease. XLP is primarily characterized by a defective...

    O. Parolini, B. Kagerbauer, I. Simonitsch-Klupp, P. Ambros… in Annals of Hematology (2002)